Abstract
The use of nucleic acid sequence-based amplification (NASBA), a continuous and isothermal method of in vitro nucleic acid amplification, was investigated for the specific identification of Escherichia coli (E. coli). A set of primers was selected from a highly conserved region of the 16S rRNA sequence of E. coli sandwiching a variable sequence to perform the amplification of bacterial RNA using NASBA. A probe was identified and shown to hybridize specifically to the amplified single-stranded RNA products of all tested E. coli isolates, including enterohemorrhagic serotype O157:H7. The high sensitivity of this assay system is most likely due to the large amplification power of NASBA and the high copy number of 16S rRNA.
This article was submitted as part of a Special Memorial Issue honoring Prof. George G. Guilbault.